BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24440556)

  • 21. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells.
    Zhang X; Zhao WE; Hu L; Zhao L; Huang J
    Arch Biochem Biophys; 2011 Aug; 512(1):96-106. PubMed ID: 21620794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
    Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
    Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
    Sheng G; Bernabe KQ; Guo J; Warner BW
    Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
    Yuan Y; Zhang A; Huang S; Ding G; Chen R
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
    Vigneron A; Roninson IB; Gamelin E; Coqueret O
    Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
    Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.
    Broude EV; Swift ME; Vivo C; Chang BD; Davis BM; Kalurupalle S; Blagosklonny MV; Roninson IB
    Oncogene; 2007 Oct; 26(48):6954-8. PubMed ID: 17486059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro‑apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells.
    Harati K; Slodnik P; Chromik AM; Behr B; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A
    Int J Oncol; 2015 Apr; 46(4):1629-36. PubMed ID: 25625225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient expression, purification and characterisation of human full-length PPARγ2 in HEK293 cells.
    Liu J; Ormö M; Nyström AC; Claesson J; Giordanetto F
    Protein Expr Purif; 2013 Jun; 89(2):189-95. PubMed ID: 23562662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometry-based FRET identifies binding intensities in PPARγ1 protein-protein interactions in living cells.
    Trümper V; von Knethen A; Preuß A; Ermilov E; Hackbarth S; Kuchler L; Gunne S; Schäfer A; Bornhütter T; Vereb G; Ujlaky-Nagy L; Brüne B; Röder B; Schindler M; Parnham MJ; Knape T
    Theranostics; 2019; 9(19):5444-5463. PubMed ID: 31534496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cells.
    Tian L; Wang C; Hagen FK; Gormley M; Addya S; Soccio R; Casimiro MC; Zhou J; Powell MJ; Xu P; Deng H; Sauve AA; Pestell RG
    Oncotarget; 2014 Sep; 5(17):7303-15. PubMed ID: 25229978
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Jiao X; Tian L; Zhang Z; Balcerek J; Kossenkov AV; Casimiro MC; Wang C; Liu Y; Ertel A; Soccio RE; Chen ER; Liu Q; Ashton AW; Tong W; Pestell RG
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.
    Are A; Aronsson L; Wang S; Greicius G; Lee YK; Gustafsson JA; Pettersson S; Arulampalam V
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1943-8. PubMed ID: 18234854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different roles of peroxisome proliferator-activated receptor gamma isoforms in prostate cancer.
    Salgia MM; Elix CC; Pal SK; Jones JO
    Am J Clin Exp Urol; 2019; 7(3):98-109. PubMed ID: 31317050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Structure Inter-Activity Relationship (QSInAR). Cytotoxicity Study of Some Hemisynthetic and Isolated Natural Steroids and Precursors on Human Fibrosarcoma Cells HT1080.
    Putz MV; Lazea M; Sandjo LP
    Molecules; 2011 Aug; 16(8):6603-20. PubMed ID: 25134765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Function and regulation of the human multidrug resistance gene.
    Chin KV; Pastan I; Gottesman MM
    Adv Cancer Res; 1993; 60():157-80. PubMed ID: 8417499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
    Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.